1-8 of 8
Section: Correction
Journal Article
Correction to: “Presentation and Management of Highly Differentiated Follicular Carcinoma of Ovarian Origin With DICER1 Gene Variants” Open Access
JCEM Case Reports, Volume 3, Issue 2, February 2025, luae256, https://doi.org/10.1210/jcemcr/luae256
Published: 21 January 2025
Journal Article
Correction to: “Acquired 11β-hydroxylase Deficiency by Inhaled Etomidate and its Analogues: A Mimic of Congenital Adrenal Hyperplasia” Open Access
JCEM Case Reports, Volume 3, Issue 1, January 2025, luae251, https://doi.org/10.1210/jcemcr/luae251
Published: 02 January 2025
Journal Article
Correction to: “Emerging Role of Gallium-68 DOTANOC PET/CT Guided Radiofrequency Ablation in the Treatment of Tumor-induced Osteomalacia” Open Access
JCEM Case Reports, Volume 2, Issue 6, June 2024, luae111, https://doi.org/10.1210/jcemcr/luae111
Published: 31 May 2024
Journal Article
Correction to: “Noninsulinoma Pancreatogenous Hypoglycemia Syndrome in a Patient With 1p36 Deletion Syndrome” Open Access
JCEM Case Reports, Volume 2, Issue 3, March 2024, luae046, https://doi.org/10.1210/jcemcr/luae046
Published: 15 March 2024
Journal Article
Correction to: “Type B Insulin Resistance Syndrome: A Rare Cause of Hypoglycemia” Open Access
JCEM Case Reports, Volume 2, Issue 3, March 2024, luae040, https://doi.org/10.1210/jcemcr/luae040
Published: 06 March 2024
Journal Article
Correction to “Severe Hypercalcemia Due to Primary Hyperparathyroidism and Heterozygous Pathogenic Variant of CYP24A1” Open Access
JCEM Case Reports, Volume 1, Issue 5, September 2023, luad125, https://doi.org/10.1210/jcemcr/luad125
Published: 13 October 2023
Journal Article
Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes” (J Clin Endo Metab Case Reports. 2023; 1(1): 10.1210/jcemcr/luac017) Open Access
JCEM Case Reports, Volume 1, Issue 1, January 2023, luad005, https://doi.org/10.1210/jcemcr/luad005
Published: 24 January 2023
Journal Article
Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes” Open Access
JCEM Case Reports, Volume 1, Issue 1, January 2023, luac027, https://doi.org/10.1210/jcemcr/luac027
Published: 28 December 2022
